Optimising implementation strategies of the first scaleup of a primary care psychological intervention for common mental disorders in Sub-Saharan Africa: a mixed methods study protocol for the optimised Friendship Bench (OptFB) by Verhey, Ruth et al.
1Verhey R, et al. BMJ Open 2021;11:e045481. doi:10.1136/bmjopen-2020-045481
Open access 
Optimising implementation strategies 
of the first scaleup of a primary care 
psychological intervention for common 
mental disorders in Sub- Saharan Africa: 
a mixed methods study protocol for the 
optimised Friendship Bench (OptFB)
Ruth Verhey   ,1,2 Charmaine Chitiyo,1,2 Sandra Ngonidzashe Mboweni,1,2 
Ephraim Chiriseri,2 Dixon Chibanda,1,2,3 Andy Healey,4 Bradley Wagenaar,5,6 
Ricardo Araya4,7
To cite: Verhey R, Chitiyo C, 
Mboweni SN, et al.  Optimising 
implementation strategies of 
the first scaleup of a primary 
care psychological intervention 
for common mental disorders 
in Sub- Saharan Africa: a 
mixed methods study protocol 
for the optimised Friendship 
Bench (OptFB). BMJ Open 
2021;11:e045481. doi:10.1136/
bmjopen-2020-045481
 ► Prepublication history and 
additional supplemental material 
for this paper are available 
online. To view these files, 
please visit the journal online 
(http:// dx. doi. org/ 10. 1136/ 
bmjopen- 2020- 045481).
Received 05 October 2020
Accepted 12 July 2021
For numbered affiliations see 
end of article.
Correspondence to
Dr Ricardo Araya;  
 ricardo. araya@ kcl. ac. uk
Protocol
© Author(s) (or their 
employer(s)) 2021. Re- use 
permitted under CC BY. 
Published by BMJ.
ABSTRACT
Introduction Common mental disorders (CMDs) are 
a leading cause of disability globally. CMDs are highly 
prevalent in Zimbabwe and have been addressed by an 
evidence- based, task- shifting psychological intervention 
called the Friendship Bench (FB). The task- shifted FB 
programme guides clients through problem- solving 
therapy. It was scaled up across 36 implementation sites 
in Zimbabwe in 2016.
Methods and analysis This study will employ a mixed- 
method framework. It aims to: (1) use quantitative survey 
methodologies organised around the Reach, Effectiveness, 
Adoption and Implementation and Maintenance evaluation 
framework to assess the current scaleup of the FB 
intervention and classify 36 clinics according to levels of 
performance; (2) use qualitative focus group discussions 
and semistructured interviews organised around the 
Consolidated Framework for Implementation Research to 
analyse determinants of implementation success, as well 
as elucidate heterogeneity in implementation strategies 
through comparing high- performing and low- performing 
clinics; and (3) use the results from aims 1 and 2 to 
develop strategies to optimise the Friendship Bench 
intervention and apply this model in a cluster randomised 
controlled trial to evaluate potential improvements among 
low- performing clinics. The trial will be registered with 
the Pan African Clinical Trial Registry ( www. pactr. org). The 
planned randomised controlled trial for the third research 
aim will be registered after completing aims one and two 
because the intervention is dependent on knowledge 
generated during these phases.
Ethics and dissemination The research protocol 
received full authorisation from the Medical Research 
Council of Zimbabwe (MRCZ A/242). It is anticipated that 
changes in data collection tools and consent forms will 
take place at all three phases of the study and approval 
from MRCZ will be sought. All interview partners will 
be asked for informed consent. The research team 
will prioritise open- access publications to disseminate 
research results.
INTRODUCTION
In the past 10 years, it has become apparent 
that mental, neurological and substance use 
disorders (MNS) are among the leading 
causes of the global disease burden.1–3 
Research has shown that 4 out of every 10 
people in low- income and middle- income 
countries (LMICs) suffer from mental disor-
ders (de Boer et al, 2008, World Health Orga-
nization, 2009a) and evidence- based mental 
health interventions have become a focus of 
research and interest.4 It has been observed 
that the poor are disproportionately affected 
by mental disorders.5 6 Less than 5% of people 
Strengths and limitations of this study
 ► Few evidence- based psychological interventions 
offered at primary healthcare level have been suc-
cessfully scaled- up in Sub- Saharan Africa; this 
study is designed to deliver detailed knowledge 
about factors that influence the scale- up of a pri-
mary care psychological intervention (the Friendship 
Bench) in an African setting.
 ► Two widely used implementation science models, 
Reach, Effectiveness, Adoption and Implementation 
and Maintenance and Consolidated Framework for 
Implementation Research, will be used to evaluate 
the implementation of this intervention, which was 
scaled up in 2016.
 ► This study focuses on evaluating the scaling up of 
evidence- based interventions and developing and 
testing implementation strategies to potentially op-
timise the routine delivery of the Friendship Bench.
 ► A limitation is that comprehensive implementation 
data are only collected three years after the scale 
up exercise.
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living in some LMIC receive any adequate treatment for 
mental health disorders.7–9 Particularly in LMIC the lack 
of resources, especially trained mental health profes-
sionals, causes suboptimal detection and management 
of common mental disorders (CMDs).10–12 Worldwide, 
efforts have been made to create sustainable and afford-
able mental health interventions in primary care.13–18 In a 
recent systematic review, only four studies were detected 
that had evaluated the implementation of a depression 
intervention scaled up in routine care.19 As it stands, the 
benefit of these evidence- based interventions is not yet 
reaching those populations most at need across LMICs.
Zimbabwe, a country in Southern Africa with a popu-
lation of 13 million has a large treatment gap for MNS. 
Studies show that over 30% of primary healthcare (PHC) 
users need mental healthcare services for mostly CMD and 
only 5% of these receive appropriate care.20 Untreated 
CMD can also lead to worsening of clinical outcomes in 
chronic conditions such as HIV21 and negatively affect 
economic outcomes too.5 The Friendship Bench (FB) 
was developed in response to the existing treatment gap 
for mental healthcare in Zimbabwe and tested for its effi-
cacy in a cluster randomised controlled trial (RCT).22
This task- shifted intervention is delivered by trained 
and supervised lay health workers (LHWs) who deliver 
problem- solving therapy (PST)23 on a bench located in 
PHC clinics. In 2016, the FB intervention was scaled up 
across Harare, Gweru and Chitungwiza and surrounding 
peri- urban communities in collaboration with the respec-
tive City Health departments.24 The FB programme was 
established in 72 City Health PHC clinics that are estab-
lished in 36 sites (different clinic types can be found in the 
same site). This scaling- up exercise involved the training 
of more than 300 LHWs in the 3 cities in Zimbabwe.24 
Maintenance funding for FB activities is provided by the 
City Health department.
All LHWs working for the FB PHC clinics in Harare, 
Gweru and Chitungwiza received the standard manual-
ised training and supervision. While existing scientific 
evidence has shown that under ideal randomised trial 
conditions the FB intervention leads to clinically signif-
icant reductions in symptoms, little implementation 
research has been carried out regarding the performance 
of FB under routine conditions as the model is being 
further scaled up across Zimbabwe.
This study will be of interest to implementation scien-
tists, policy- makers and researchers working to scale- up 
primary care psychological interventions in LMICs glob-
ally. Results from this study have the potential to inform 
future scaleup and maintenance of task- shared psycholog-
ical interventions into routine Ministry of Health primary 
care settings.
Preliminary observations
Preliminary work had revealed that FB activities were 
irregular over the implementation sites. FB related data 
collection was often unreliable due to various reasons 
such as the delivering agents not having been trained on 
data collection, and the FB programme data not being 
reported to the authorities as part of the clinic activities. 
Only estimates for client numbers for 2016–2018 with a 
programme reach decline from 27 967 clients in 2016 to 
6688 in 2018 for all of the 36 sites were available. Sites 
in Harare had continued to offer the programme. In the 
two other cities (Gweru and Chitungwiza), the health 
authorities had ceased to support the FB programme 
and delivering agents had been told to focus on other 
programmes such as HIV- related activities. It was unclear 
how many FB activities had been carried out. In order to 
receive continued support, the FB programme should be 
integrated with other PHC programmes such as HIV care. 
Data collection efforts need to be simplified and deliv-
ering agents trained. Data need to be gathered and anal-
ysed regularly using implementation science principles. 
Furthermore, the FB organisation should engage closely 
with healthcare providers and policy- makers to ensure 
successful and continued programme implementation.
Overall study goal
This research uses a mixed- method study design and 
widely used implementation frameworks to systemati-
cally analyse the performance of clinics, determinants 
of this performance, including implementation strate-
gies that might differentiate high- performing versus low- 
performing clinics, and develop and test an enhanced 
implementation strategy to improve the performance of 
clinics in three cities in Zimbabwe. The study is designed 
to be conducted in three phases with corresponding aims.
First (aim 1), we plan to examine how the FB is 
performing under real- world implementation conditions 
and classify existing clinics with FB into high- performing 
versus low- performing sites using differences in Reach, 
Effectiveness, Adoption and Implementation and Main-
tenance (RE- AIM) outcomes.25 26
Second (aim 2), we will analyse the determinants 
of heterogeneity in the results of phase 1 comparing 
high- performing versus low- performing clinics, mainly 
using the Consolidated Framework for Implementa-
tion Research (CFIR) framework27 and rigorously docu-
menting changes to the original FB protocol and current 
implementation strategies in use.
Third (aim 3), we will develop and test an optimised 
package of FB implementation strategies based on the 
results of phase 2 and measure the improvement among 
low performing clinics using RE- AIM outcomes.
Study setting
The study will be conducted in PHC clinics in Harare, 
Gweru and Chitungwiza.
Most of the clinics in the three cities are located in 
comparable areas which are characterised by high popu-
lation density and informal income generating activities 
often occurring in the vicinity of the clinics. Depending 
on their size, PHC clinics serve between 20 000 and 80 000 
people from the most socioeconomically disadvantaged 
sectors of the population. Clinics are differentiated into 
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poly, satellite and family health service clinics according 
to the size of the clinic and the range of services offered.
The most comprehensive services are offered in a 
Polyclinic such as prenatal, postnatal and perinatal 
care, opportunistic infections (eg, TB treatment), and 
specialised NGO- based programmes (HIV testing and 
management, male circumcision, communicable disease 
awareness). Satellite and Family health clinics (FHS) 
offer less services. Medical doctors are not permanently 
present but hold clinics on specific days in poly clinics. 
This influences the clinic user population’s composition 
on these particular days (eg, HIV clinic day).
Clinics in Harare, Chitungwiza and Gweru are grouped 
and located in the same geographical facility and these 
are counted as one FB implementation site. Data will be 
collected in 36 implementation sites (n=28 in Harare; n=4 
in Gweru; n=4 in Chitungwiza). Of these 26 Poly clinics, 6 
are FHS and 4 satellite clinics (see figure 1).
Depending on their size and catchment area, FB imple-
mentation sites have between one (1) and fourteen (14) 
LHWs who deliver the FB intervention on benches in the 
clinic premises during clinic opening times. Clinic users 
are informed about the about FB services and mental 
health through group or individual talks in the clinic’s 
waiting areas. Community members are also directly 
in contact with LHWs during outreach activities in the 
community.
METHODS
This study proposes a rigorous analysis of the multiple 
interconnecting factors using two internationally 
recognised implementation research methods—the 
RE- AIM model26 and the CFIR27 which will be described 
in more detail below. Both conceptual frameworks have 
been used widely in implementation research for health-
care delivery in order to deepen the understanding and 
evaluation of interventions such as the FB. The study has 
three research aims which are linked contextually to each 
other and are described in detail below.
Patient and public involvement
Patients and/or the public will be involved in the stake-
holder meetings; they were not involved in the design, nor 
will they be involved in the study conduct, or reporting, 
or dissemination plans of this research project.
Methods aim 1
A thorough analysis of the existing routine health infor-
mation system data collected by the Harare, Gweru and 
Chitungwiza City Health authorities will be carried out 
to learn about the FB activities at individual clinic level. 
These data consist of user numbers, age, gender, HIV 
status, clients’ screening tool scores preintervention and 
postintervention as well as complete use of screening 
tool, and number of sessions.
We will use the RE- AIM evaluation framework to eval-
uate the current implementation performance of the FB 
intervention after 3 years of implementation experience.
Routinely collected data will be used to assess the FB 
intervention’s real- world and pragmatic performance: 
Reach, Effectiveness, Adoption, Implementation and 
Maintenance. The research team which consists of expe-
rienced global mental health researchers and clinicians 
will develop indicators for each of the RE- AIM domains 
using the www. re- aim. org website to support us and base 
our decisions on expert consensus and availability of data. 
These indicators will then be used to design a question-
naire to guide the RE- AIM related data collection. Each 
indicator will comprise a numerator and a denominator 
populated with data collected from the clinic records and 
the planned observations.
The data on the FB implementation will be analysed for 
each of the 36 participating clinics. Routinely collected 
data includes clinical registries for both nurses and LHWs 
and data from the FB Register (commonly known as 
the ‘green book’) where the LHWs record beneficiary 
information.
In addition, LHWs will be observed during all aspects 
of their work, including giving health talks, interacting 
with clients, and delivering the FB intervention. We will 
observe and record whether all FB related tools such as 
questionnaires and intervention tools are used.
In order to collect additional necessary data for AIM 1, 
key respondents will be interviewed using a questionnaire 
that will be developed by the research team.
We plan to interview at least two LHWs per clinic and 
in clinics with more than two LHWs; we will interview 
50% of the present LHWs by randomly selecting them. 
Papers with their names will be put in a container from 
which an RA will pull out the appropriate number in the 
LHWs’ presence. We will always interview the supervisor 
LHW of each clinic if this position is taken in a particular 
clinic. We will also interview the nurse in charge in every 
clinic and the associated district health promoting offi-
cers (DHPOs) (n=10). Data will be collected from June to 
September 2019 in all participating sites.
The data collection will be carried out by two research 
coordinators who will lead two teams of four trained and 
Figure 1 Clinic type distribution for Harare, Gweru and 
Chitungwiza. PHC, primary healthcare.
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supervised research assistants (RAs). The teams will visit 
each clinic for 2 days. The clinics will be sensitised about 
the FB team visit a week prior. The RAs will be trained 
to interview, to observe and record the FB- related activi-
ties in the clinic and how to enter the data digitally using 
tablet computers. They will be trained on data checking, 
cleaning and uploading.
Furthermore, we are planning to audio- record FB 
sessions with consenting clients (two per site, n=72). 
We will approach, where possible, all incoming clients 
seeking services and ask them for informed consent to 
allow us to record their session with the FB LHWs. We 
aim to record as many as possible but at least two per site.
The recordings will be translated, transcribed and rated 
according to the FB fidelity checklist.
The FB fidelity checklist assesses for communication 
skills of the counsellor, the level of psychoeducation that 
is done, and the adherence to the PST steps that the 
FB counsellor is trained to deliver (see Supplementary 
Appendix A for full fidelity checklist which was developed 
for the RCT22). The assessments of audio recordings will 
be done by trained FB research team members who will 
prepare an audio recorder which will be left with the FB 
counsellor after a client has given consent. The audio 
recording device will be retrieved by the RA when the 
LHW has indicated that the session is done.
In the event that no clients come to the clinic on both 
days that the FB team visits the site or no client consents 
to have their session audio recorded, this will be entered 
as missing. Due to logistic and financial constraints a 
repeat visit to a particular clinic will not be possible.
All respondents will be asked to answer the questions 
with regards to FB activities in the past month. According 
to their position with regards to FB activities, questions 
might be formulated slightly differently.
The questionnaires will be administered using tablet 
computers (Lenovo); all observational data will be entered 
digitally after their correctness has been ascertained by 
asking interviewees to show evidence as applicable. Ques-
tionnaires and observation guides are programmed into 
the tablets using Kobotoolbox (https://www. koboto-
olbox. org) which is a data collection tool. Collected data 
will be cleaned and uploaded daily to a password secured 
server.
The research team will also observe FB- specific activi-
ties such as health and ‘mobilisation’ talks that are given 
by the clinic staff including the LHWs while patients are 
waiting to be seen.
A stakeholder meeting will be held once aim 1 data are 
completed and the data are analysed. At this meeting, 
the research team will present the results from aim 1 and 
discuss potential reasons why we might see the differ-
ences in implementation across sites with stakeholders. 
This meeting will be attended by all relevant clinic staff, 
health authority officers as well as clients. Information 
from stakeholders will be used to select and prioritise 
CFIR constructs to include in qualitative interview guides 
for aim 2.
Data analysis aim 1
The goal of aim 1 is to classify the 36 FB implementa-
tion sites on their performance based on the RE- AIM 
outcomes. Our methods will follow similar classification 
efforts previously published.28 Clinics will be first ranked 
according to their performance within each individual 
measure. Clinics score on all indicators within one 
construct (for example reach) will be averaged. For each 
of the RE- AIM constructs, every clinic will thus have an 
averaged ranking.
These domain- based rankings will be averaged per 
clinic rankings giving an overall ranking by calculating 
simple means of all domain rankings. This procedure will 
be carried out by two independent individuals and any 
differences will lead to a redoing of the process. In case 
of same outcomes for clinics, we will treat these partic-
ular clinics as being on the same rank. This will give us 
a final composite rank for each clinic which will be used 
to determine the 10 highest and 10 lowest performing 
clinics that will be qualitatively assessed in aim 2.
Methods aim 2
With the aim to understand the determinants of imple-
mentation success, as well as differences in implemen-
tation strategies employed, aim 2 will use focus- group 
discussions organised around the CFIR.29–31 Through 
these qualitative methods, we aim to gain a deeper under-
standing of the factors that contribute to the successful 
implementation comparing high- performing with low- 
performing clinics. The CFIR framework focuses on an 
overview of potential multilevel determinants of health-
care delivery. It was designed to help understand inte-
grated implementation determinants across multiple 
levels (clients; implementers; organisations; contexts; 
processes).
For the present study, we will focus on determinants of 
implementation success, taking lessons from both high- 
performing and low- performing clinics to inform the 
development of an improved package of implementation 
strategies targeting identified barriers.
Focus group discussions (FDGs) with key infor-
mants (LHWs, nurses, DHPOs, clients) of the 10 high- 
performing and 10 low- performing clinics will be carried 
out by trained qualitative researchers. The FB- specific 
interview guides for these group discussions and inter-
views will be developed by the study team in a sequence 
of internal project meetings using the online technical 
support website wwwcfirguideorg. The results of aim 1 will 
guide us in designing the interview guides for the FDGs.
The outcome of the stakeholders meeting in which we 
present the results of aim 1 will also give us insight on the 
importance of constructs which we will take into account 
when designing the CFIR interview guides.
Interview guides will be translated into the local 
language Shona and all group discussions will be audio 
recorded, transcribed and translated to English. All 
discussions will be held in the local language.
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The FGD participants will be selected from all 10 low- 
performing and high- performing clinics, respectively. 
We will interview LHWs, nurses, DHPOs in their role as 
implementers as well as clients as recipients of the inter-
vention. Nurses and DHPOs will be invited to joined meet-
ings. We will conduct FGDs for all available LHWs at every 
selected clinic. We will ask the selected LHWs to purpo-
sively suggest two clients each, whom we will then invite 
to FGDs in each of the selected clinics. In case a client 
declines participation, we will ask for another suggestion.
FDGs will take place in clinics or, if not possible, in the 
FB office in Harare.
Data analysis aim 2
CFIR analyses will follow the original Damschroder meth-
odology previously published.30 Briefly, two independent 
local Zimbabwean reviewers will code each FGD tran-
script according to the selected CFIR constructs. Differ-
ences will be discussed and revised until final codes are 
agreed on. Facility- level case memos will be organised by 
the relevant CFIR construct, using each new transcript 
to confirm and refine statements until all transcripts are 
coded. This process will be closely supported by the whole 
research team. Each clinic will have two case memos, one 
for LHWs and other implementers and one for clients.
Using case memos and supporting transcripts, the 
same two coders will independently rate CFIR constructs 
on valence (X (mixed); 0 (neutral); + (construct has a 
positive effect on implementation) or – (construct has a 
negative influence on implementation). Once drafted, 
the entire research team will meet and use a deliberated 
consensus to finalise memos, constructs, and valence. 
These data will be mapped on a matrix template with the 
goal of identifying constructs that differ between facil-
ities with high and low performance to identify factors 
relevant for the success of the implementation. Anal-
yses will progress with visual inspection of patterns in 
constructs and valence by high vs low performing clinics, 
as well as examining median and mean valence by high- 
performing versus low- performing clinics. Once distin-
guishing constructs are identified, the team will re- review 
case memos and coded transcripts to gather more infor-
mation on constructs.
Aim 3
In aim 3, we will develop a package of optimised Friend-
ship Bench (OptFB) implementation strategies matched 
to key barriers identified in the previous phases of this 
study. Using CFIR data on barriers/facilitators to high- 
quality FB implementation, we will use the CFIR- Expert 
Recommendation for Implementation Change (ERIC) 
matching tool to examine and select implementation 
strategies to address key CFIR constructs discriminating 
between high and low performing clinics in aim 1 
(https:// cfirguide. org/ choosing- strategies/).32 33 Once a 
preliminary list is developed by our team, the CFIR- ERIC 
matching tool32 will be used to prioritise those strategies 
that are found to be most likely to address CFIR barriers 
in low- performing clinics.33 34
We will engage in a participatory stakeholder Delphi 
rating exercise to select specific strategies. This will be 
followed by the research team specifying and tailoring 
the strategies for the Zimbabwean context by including 
the additional information gained from the stakeholders. 
Aspects of feasibility, affordability and effectiveness will 
guide this process in order for the package to be mean-
ingful and effective.35 Strategies currently in use by high- 
performing clinics will be also considered for the OptFB 
implementation strategies.
This OptFB package or intervention of improved strat-
egies will be tested in low- performing clinics. Ongoing 
RE- AIM data are being collected on a monthly basis in 
each clinic. Using these data on RE- AIM outcomes, we 
will reclassify clinics using a similar process as in aim 1. 
We will then identify the 18 lowest performing clinics 
and randomly select 12 clinics to deliver the OptFB and 
6 to act as control clinics over a period of 6 months. The 
primary outcome will be a composite measure of RE- AIM 
indicators estimated at 6 months after the commence-
ment of the implementation of the OptFB intervention. 
We will estimate changes in this composite measure of 
implementation before and at 6 months after starting 
the delivery of OptFB in all clinics. We will compare 
the difference in means or proportions between the 
clinics receiving the OptFB and the control clinics using 
the routinely collected data. Secondary outcomes will 
examine performance of each of the RE- AIM outcomes 
separately and clinical effectiveness results at individual 
level. The latter will be based on individual scores on the 
SSQ on a minimum of 20 random individuals per clinic 
during the 6- month period.
No sample size calculation has been estimated since 
there are no previous studies on which to estimate an 
effect size, the number of clinics is small, and the main 
outcomes are averaged data representing clusters. None-
theless, we expect to see larger improvements in the 
RE- AIM composite index score in the clinics receiving 
OptFB compared with the control clinics over the 6 
months. As a secondary outcome measure, clinical effec-
tiveness will be assessed based on changes on SSQ scores 
from baseline to 6 months for a sample of 360 individ-
uals (18 clinics with 20 individuals each), but we do not 
expect this sample would have enough power to detect 
small differences in effectiveness across the two group of 
clinics. Thus, comparisons on clinical effectiveness must 
be considered purely descriptive and exploratory and 
interpreted with caution. In any case, the main outcomes 
of interest in this study are implementation outcomes 
subsumed under the domains included in the RE- AIM 
framework.
Data analysis aim 3
We will use a difference- in- differences analysis comparing 
the groups over time. Means or proportions on outcome 
data will be compared across groups using descriptive 
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statistics. Regression models will be used to estimate the 
effect of the intervention on the main outcomes. General 
estimating equations with robust standard errors will be 
used to control for clustering. Potential confounders 
will be determined a priori and included in the regres-
sion models. Standard errors, confidence intervals and p 
values will be obtained. A similar secondary analysis will 
be conducted with the secondary outcome measures.
Health economic analysis
Site- level data will be collected on fidelity to the OptFB 
implementation strategies, along with activities and 
resource inputs required to deliver improvement strat-
egies and OptFB delivery costs. Economic modelling 
will be used to combine this information with data and 
evidence on clinical impact and implementation effec-
tiveness to evaluate the cost effectiveness of the OptFB 
programme.36
We will also revisit clinics and re- engage with stake-
holders in FGD to explore level of change in the identi-
fied CFIR domains in the intervention arm clinics.
After completion of the trial, the strategy will also 
be implemented in the control arm clinics to increase 
the overall performance in all of participating lower 
performing clinics.
DISCUSSION
This study will contribute to the knowledge about scaling 
up of an evidence- based task- shifted intervention in a 
LMIC. This is a unique opportunity to analyse the FB in 
a real- world setting. As mentioned above, not many inter-
ventions have been scaled up from LMICs and therefore 
there is a dearth of information on how implementation 
strategies can be used in order to ensure a strong scaling 
up. With this study, we hope to learn which barriers and 
enablers are at play in the FB scale up process. This is 
particularly important for us as we are expanding the FB 
services throughout Zimbabwe and beyond to meet the 
population’s needs for accessible and acceptable mental 
healthcare. This effort has to be undertaken with the aim 
of having high fidelity to the programme while consid-
ering contextual aspects. Using implementation science 
principles will help us to give theoretical justification and 
describe specifications for application for those imple-
mentation strategies that we will devise after having gone 
through the different stages of this research process. 
Evidence- based, clear and applicable guidelines of how 
to implement our evidence- based intervention in PHC 
settings will be created and can then subsequently be 
used to ensure a strong implementation of FB.
Ethics and dissemination
This research protocol has been approved by the Medical 
Research Council Zimbabwe (MRCZ), MRCZ/A/2428 
and the Joint Research Council (JREC), 79/19. Results 
will be disseminated in peer- reviewed journals and 
conferences.
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